800 new homes in Flemingsberg

There are plans for 800 new student and researcher residences in Campus Flemingsberg. The construction project is strategically located in the heart of Flemingsberg, which is one of Stockholm’s most prominent regional city centers.

Earlier this fall, ByggvVesta announced that they had entered into an agreement for land acquisition with the Clara Foundation and Akademiska Hus for the construction of 800 student and researcher residences in central Flemingsberg. The interest in developing Campus Flemingsberg was sparked back in 2017 when ByggvVesta entered into an agreement with the Clara Foundation for property acquisition. This marked the beginning of the project to build 800 residences in Flemingsberg. Now, we are pleased to announce that ByggvVesta is actively participating in the efforts to further strengthen Campus Flemingsberg as a flourishing innovation environment and a central hub for research and education.

“Housing is what is needed to create a vibrant campus area and keep people on campus, and Flemingsberg is somewhat unique because there are so many actors, property owners, and institutions in one place”, says Marcus Nyström, project manager at ByggvVesta.

Built in two stages
Marcus explains that the construction is taking place in two stages, with the first stage of over 400 residences sold to EQT Exeter, a long-term property investor aiming to meet local housing needs and promote the development of Campus Flemingsberg. ByggvVesta, on the other hand, is actively involved in developing the property with the goal of completing the project from early 2026 to the mid-2026. After that, the start of the second stage is planned.

An expansive area
ByggvVesta has long focused on growth and student areas, where they have observed a demand for new and attractive residences. When asked why they chose to invest in Campus Flemingsberg, Marcus responds:

“Flemingsberg is an interesting development area, it is very expansive, and there is a lot happening. We believe that Campus Flemingsberg needs to be elevated and developed, and we are happy to contribute in the way we can and are good at”.

A common meeting place
Marcus also reveals that, in connection with the construction, a common meeting place is being created in and around the central square of the planning area, with the aim of helping the campus area grow. This space will accommodate, for example, a new restaurant or café, as well as a combined lounge/study area for students.

Read more about ByggvVesta here

Read more about EQT Exeter here

South Korean Game Investors Visited Press Start Game Hub in Flemingsberg

A delegation of investors from some of South Korea’s leading game companies visited Press Start Game Hub in Flemingsberg yesterday, a growing hub for game innovation and entrepreneurship in Europe. The visit was part of an initiative organized by Business Sweden, aimed at strengthening ties between the Swedish and South Korean gaming industries.

The Flemingsberg Science Foundation welcomes Angela Hoyer as the new Networks and Event Manager

With a background as a researcher at Karolinska Institutet and experience from academia, industry, and networking, Angela Hoyer, the new Networks and Event Manager at the Flemingsberg Science Foundation, is passionate about developing the life science sector. In her new role, Angela looks forward to creating meeting places where collaborations can grow, while also contributing to Flemingsberg’s continued development as a strong international hub for research and innovation.

A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

Go to Top